Pablo Vega

655 total citations
33 papers, 445 citations indexed

About

Pablo Vega is a scholar working on Epidemiology, Clinical Psychology and Psychiatry and Mental health. According to data from OpenAlex, Pablo Vega has authored 33 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 13 papers in Clinical Psychology and 12 papers in Psychiatry and Mental health. Recurrent topics in Pablo Vega's work include Substance Abuse Treatment and Outcomes (10 papers), Schizophrenia research and treatment (9 papers) and Suicide and Self-Harm Studies (6 papers). Pablo Vega is often cited by papers focused on Substance Abuse Treatment and Outcomes (10 papers), Schizophrenia research and treatment (9 papers) and Suicide and Self-Harm Studies (6 papers). Pablo Vega collaborates with scholars based in Spain, Palestinian Territory and United States. Pablo Vega's co-authors include Néstor Szerman, Ignacio Basurte-Villamor, F. Árias, Carlos Roncero, José Martı́nez-Raga, Consuelo Morant, Enriqueta Ochoa Mangado, Marta Torrens, Miguel Casas and Lara Grau‐López and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Journal of Hepatology.

In The Last Decade

Pablo Vega

30 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pablo Vega Spain 14 177 175 141 88 70 33 445
A. Thomas McLellan United States 7 157 0.9× 50 0.3× 96 0.7× 32 0.4× 26 0.4× 8 414
Ralph E. Tarter United States 7 214 1.2× 99 0.6× 218 1.5× 23 0.3× 43 0.6× 10 444
Gloria García–Fernández Spain 12 182 1.0× 85 0.5× 142 1.0× 40 0.5× 59 0.8× 48 482
Danilo Antônio Baltieri Brazil 15 226 1.3× 77 0.4× 236 1.7× 64 0.7× 99 1.4× 44 640
Wilhelm Burtscheidt Germany 10 157 0.9× 92 0.5× 95 0.7× 24 0.3× 23 0.3× 17 344
Nanna Gilliam Toftdahl Denmark 6 114 0.6× 196 1.1× 101 0.7× 87 1.0× 31 0.4× 6 400
Rodrigo Marín-Navarrete Mexico 12 191 1.1× 70 0.4× 113 0.8× 66 0.8× 52 0.7× 66 509
Allan Lundy United States 16 170 1.0× 101 0.6× 210 1.5× 75 0.9× 50 0.7× 26 605
Wei Jie Ong Singapore 13 58 0.3× 69 0.4× 136 1.0× 172 2.0× 27 0.4× 28 418
I. van Bokhoven Netherlands 8 38 0.2× 47 0.3× 229 1.6× 131 1.5× 26 0.4× 10 516

Countries citing papers authored by Pablo Vega

Since Specialization
Citations

This map shows the geographic impact of Pablo Vega's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Vega with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Vega more than expected).

Fields of papers citing papers by Pablo Vega

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pablo Vega. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Vega. The network helps show where Pablo Vega may publish in the future.

Co-authorship network of co-authors of Pablo Vega

This figure shows the co-authorship network connecting the top 25 collaborators of Pablo Vega. A scholar is included among the top collaborators of Pablo Vega based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pablo Vega. Pablo Vega is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roncero, Carlos, et al.. (2025). Is there a risk of esketamine misuse in clinical practice?. Therapeutic Advances in Drug Safety. 16. 1591762909–1591762909. 2 indexed citations
2.
Carballada, Francisco, Cristina Blasco, Montserrat Álvaro‐Lozano, et al.. (2025). Molecular Signatures of Aeroallergen Sensitization in Pediatric Populations: A Comparative Study Across Spanish Cities. International Journal of Molecular Sciences. 26(7). 2963–2963.
3.
Szerman, Néstor, et al.. (2024). Tobacco use disorder in patients with other mental disorders: a dual disorder perspective from clinical neuroscience. Frontiers in Psychiatry. 15. 1427561–1427561. 2 indexed citations
4.
Horwitz, Mara E. Murray, Kaku So‐Armah, Christina Yarrington, et al.. (2024). Associations between Health-Related Social Needs and Postpartum Linkage to Care. American Journal of Preventive Medicine. 68(4). 707–716.
5.
Szerman, Néstor, et al.. (2024). Cariprazine as a maintenance treatment in dual schizophrenia: a 6-month observational study in patients with schizophrenia and cannabis use disorder. International Clinical Psychopharmacology. 40(3). 167–175. 3 indexed citations
6.
Basurte-Villamor, Ignacio, Pablo Vega, Carlos Roncero, et al.. (2022). A Feasibility Study of Patients with Major Depression and Substance Use Disorders: Vortioxetine as Maintenance Treatment. Neuropsychiatric Disease and Treatment. Volume 18. 965–976. 4 indexed citations
7.
Szerman, Néstor, Ignacio Basurte-Villamor, Pablo Vega, et al.. (2022). Is there such a thing as gambling dual disorder? Preliminary evidence and clinical profiles. European Neuropsychopharmacology. 66. 78–91. 9 indexed citations
8.
Vega, Pablo, et al.. (2022). Results of a Hepatitis C Micro-Elimination Program in Two Addiction Centers Among Subjects With Substance Use Disorder. Substance Abuse Research and Treatment. 16. 1941682802–1941682802. 1 indexed citations
9.
Szerman, Néstor, F. Árias, Jaime Algorta, et al.. (2021). Effectiveness of tianeptine in patients with major depressive disorder and substance use disorder.. PubMed. 49(4). 135–144. 1 indexed citations
10.
Szerman, Néstor, Ignacio Basurte-Villamor, Pablo Vega, et al.. (2020). Once-Monthly Long-Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co-occurring Substance Use Disorders: A Multicentre, Observational Study. Drugs - Real World Outcomes. 7(1). 75–83. 23 indexed citations
11.
Szerman, Néstor, Francisco Ferre, Ignacio Basurte-Villamor, et al.. (2020). Gambling Dual Disorder: A Dual Disorder and Clinical Neuroscience Perspective. Frontiers in Psychiatry. 11. 589155–589155. 15 indexed citations
12.
Roncero, Carlos, Pablo Ryan, Richard Littlewood, et al.. (2018). Practical steps to improve chronic hepatitis C treatment in people with opioid use disorder. SHILAP Revista de lepidopterología. Volume 11. 1–11. 10 indexed citations
13.
Roncero, Carlos, Pablo Vega, José Martı́nez-Raga, & Marta Torrens. (2017). Hepatitis C Crónica y usuarios con un historial de inyección de drogas en España: evaluación de la población, retos para un tratamiento efectivo.. Adicciones. 29(2). 71–73. 7 indexed citations
14.
Roncero, Carlos, et al.. (2017). Treatment of Comorbid Alcohol Dependence and Anxiety Disorder: Review of the Scientific Evidence and Recommendations for Treatment. Frontiers in Psychiatry. 8. 173–173. 43 indexed citations
15.
Szerman, Néstor, José Martı́nez-Raga, Rubén Baler, et al.. (2017). Joint statement on dual disorders: Addiction and other mental disorders. Salud Mental. 40(6). 245–247. 12 indexed citations
16.
Árias, F., et al.. (2016). Bipolar disorder and substance use disorders. Madrid study on the prevalence of dual disorders/pathology. Adicciones. 29(3). 186–194. 31 indexed citations
17.
Roncero, Carlos, Pablo Vega, José Martı́nez-Raga, et al.. (2014). Professionals’ perceptions about healthcare resources for co-occuring disorders in Spain. International Journal of Mental Health Systems. 8(1). 35–35. 5 indexed citations
18.
Szerman, Néstor, Pablo Vega, Lara Grau‐López, et al.. (2014). Dual Diagnosis Resource Needs in Spain: A National Survey of Professionals. Journal of Dual Diagnosis. 10(2). 84–90. 16 indexed citations
19.
Árias, F., Néstor Szerman, Pablo Vega, et al.. (2013). Cocaine abuse or dependency and other psychiatric disorders. Madrid study on dual pathology. Revista de Psiquiatría y Salud Mental (English Edition). 6(3). 121–128. 16 indexed citations
20.
Szerman, Néstor, Jorge López‐Castromán, F. Árias, et al.. (2012). Dual Diagnosis and Suicide Risk in a Spanish Outpatient Sample. Substance Use & Misuse. 47(4). 383–389. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Thomas McLellan Breakdown of academic impact, for papers by Ralph E. Tarter Breakdown of academic impact, for papers by Gloria García–Fernández Breakdown of academic impact, for papers by Danilo Antônio Baltieri Breakdown of academic impact, for papers by Wilhelm Burtscheidt Breakdown of academic impact, for papers by Nanna Gilliam Toftdahl Breakdown of academic impact, for papers by Rodrigo Marín-Navarrete Breakdown of academic impact, for papers by Allan Lundy Breakdown of academic impact, for papers by Wei Jie Ong Breakdown of academic impact, for papers by I. van Bokhoven
Rankless by CCL
2026